Introduction to Optimizing Sequencing Maintenance Strategies In Her2 Metastatic Breast Cancer
Exploring Optimizing Sequencing Maintenance Strategies In Her2 Metastatic Breast Cancer reveals several interesting facts. Erika Hamilton, MD, Sarah Cannon Research Institute, Nashville, TN, comments on novel treatment
Optimizing Sequencing Maintenance Strategies In Her2 Metastatic Breast Cancer Comprehensive Overview
Dr. Kelly McCann, of the UCLA Health David Geffen School of Medicine, shares her expert insights on In this interview, Dr. Kelly McCann, UCLA Health, outlines key considerations for Claudio Vernieri, MD, PhD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, discusses the various treatment options ...
Sara M. Tolaney, MD, MPH, discusses third-line
Summary & Highlights for Optimizing Sequencing Maintenance Strategies In Her2 Metastatic Breast Cancer
- Erika Hamilton, MD, Sarah Cannon Research Institute, Nashville, TN, explores how clinicians can navigate
- In this video
- This content has been developed for healthcare professionals only. Patients who seek health information should consult with their ...
- HER2
- Erika Hamilton, MD, Sarah Cannon Research Institute, Nashville, TN, reflects on the expanding treatment landscape of ...
Stay tuned for more updates related to Optimizing Sequencing Maintenance Strategies In Her2 Metastatic Breast Cancer.
